Physician profile
Brandon D West
NPI 1871598425
$1,703.04
in general payments reported to CMS, 2019-2025
18 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $189 · 2023: $108 · 2024: $1,086 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Consulting Fee: $580 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.80 |
| Consulting Fee | $580.00 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $727.68 | 2024 | |
| Incyte Corporation | $136.36 | 2023-2025 | Jakafi, Monjuvi, Niktimvo |
| Alexion Pharmaceuticals, INC. | $134.70 | 2024 | |
| Coherus Oncology, INC. | $133.28 | 2021-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $106.95 | 2021 | |
| Seagen INC. | $81.99 | 2022 | |
| Legend Biotech USA INC. | $58.54 | 2024-2025 | Carvykti |
| Abbvie INC. | $45.88 | 2025 | |
| Pfizer INC. | $41.71 | 2024 | |
| Tersera Therapeutics LLC | $39.93 | 2025 | Zoladex |
| Jazz Pharmaceuticals INC. | $38.35 | 2024 | |
| Lilly USA, LLC | $29.83 | 2024 | Verzenio |
| Janssen Biotech, INC. | $25.34 | 2025 | Erleada, Rybrevant, Akeega |
| Astrazeneca Pharmaceuticals LP | $25.15 | 2024 | Calquence |
| Takeda Pharmaceuticals U.S.A., INC. | $20.83 | 2024 | Fruzaqla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $20.80 | 2024 | |
| Beone Medicines USA, INC. | $19.38 | 2025 | Brukinsa |
| Kite Pharma, INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.